BIOASTER

Evaluation of the clinical performance of two new onchocerciasis rapid diagnostic tests in districts targeted for elimination in Ghana

Current diagnostic methods for onchocerciasis lack sufficient utility, sensitivity or specificity. Two new lateral flow assays developed by Bioaster and Global Access Diagnostics (BA/GADx) and Drugs and Diagnostics for Tropical Diseases (DDTD) multi-antigen test Biplex Version C...